FDA — authorised 20 May 1999
- Application: NDA021042
- Marketing authorisation holder: MERCK
- Local brand name: VIOXX
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Vioxx in United States
FDA authorised Vioxx on 20 May 1999
Marketing authorisations
FDA — authorised 20 May 1999
- Application: NDA021052
- Marketing authorisation holder: MERCK
- Local brand name: VIOXX
- Indication: SUSPENSION — ORAL
- Status: approved
Other Immunology approved in United States
Frequently asked questions
Is Vioxx approved in United States?
Yes. FDA authorised it on 20 May 1999; FDA authorised it on 20 May 1999.
Who is the marketing authorisation holder for Vioxx in United States?
MERCK holds the US marketing authorisation.